Patrick G. G. Dear 3/A
3/A · DOV PHARMACEUTICAL INC · Filed May 25, 2007
Insider Transaction Report
Form 3/AAmended
Holdings
Series C Convertible Preferred Stock
→ Common Stock (12,225,672 underlying)Series D Convertible Preferred Stock
→ Common Stock (19,102,612 underlying)
Footnotes (2)
- [F1]The Series C Convertible Preferred Stock is convertible into common stock at any time, at the holders' election, between May 11, 2007 and June 10, 2007 at a conversion rate of 191.02612143 shares of common stock for one share of Series C Convertible Preferred Stock. All shares of Series C Convertible Preferred Stock not converted on June 10, 2007 shall be automatically converted to common stock.
- [F2]The Series D Convertible Preferred Stock is convertible into common stock at any time after May 11, 2007, to the extent that the Reporting Persons would not beneficially own shares of capital stock having in excess of 9.99% of the voting power of Dov immediately after giving effect to such conversion. The Series D Convertible Preferred Stock has no expiration date and is convertible into common stock at a conversion rate of 191.02612143 shares of common stock for one share of Series D Convertible Preferred Stock.